首页> 外文OA文献 >The Anticancer Effect of Histone Deacetylase Inhibitors and Combination with the Cytotoxic Agents in Lung Cancer Cells: Biological Analyses for Future Clinical Application

【2h】

The Anticancer Effect of Histone Deacetylase Inhibitors and Combination with the Cytotoxic Agents in Lung Cancer Cells: Biological Analyses for Future Clinical Application

机译：组蛋白脱乙酰酶抑制剂的抗癌效果与肺癌细胞中细胞毒性剂的组合：未来临床应用的生物学分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Rintaro Noro; Akihiko Miyanaga; Tsuneo Shimokawa; Hidehiko Kuribayashi; Hideaki Mizutani; Yuji Minegishi; Tetsuya Okano; Masahiro Seike; Chie Soeno; Kiyoko Kataoka; Kuniko Matsuda; Akinobu Yoshimura; Akihiko Gemma;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells [J] . MateenS., RainaK., JainA.K., Epigenetics: official journal of the DNA Methylation Society . 2012,第10期

机译：组蛋白脱乙酰基酶抑制剂与水飞蓟宾联合对非小细胞肺癌的表观遗传修饰和p21-cyclin B1关联的抗癌作用
2. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines [J] . ShirsathN., RathosM., ChaudhariU., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2013,第2期

机译：细胞周期蛋白依赖性激酶抑制剂P276-00对人非小细胞肺癌细胞株丙戊酸（具有组蛋白脱乙酰基酶抑制活性的抗癫痫药）的抗癌作用增强
3. The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity [J] . Nataly Tarasenko, Gania Kessler-Icekson, Pnina Boer, Investigational New Drugs . 2012,第1期

机译：组蛋白脱乙酰基酶抑制剂丁酰氧基甲基二乙基磷酸酯（AN-7）保护正常细胞抵抗抗癌药的毒性，同时增强其抗癌活性
4. Epigenetic Silencing of Caspase-8: A Novel Mechanism of Drug Resistance Which Can Be Overcome by Demethylating Agents, Histone Deacetylase Inhibitors, IFNy or Caspase-8 Gene Transfer [C] . S. Fulda, K.-M. Debatin European Haematology Association . 2002

机译：Caspase-8的表观遗传沉默：通过去甲基化试剂，组蛋白脱乙酰酶抑制剂，IFNY或Caspase-8基因转移可以克服一种新型耐药机理
5. Enhancing the Therapeutic Effects of Low Doses of Ionizing Radiation in Non-Small Cell Lung Cancers Using a Combination of PARP Inhibitors and DNA Demethylating Agents. [D] . Biondi, Christopher Anthony. 2016

机译：使用PARP抑制剂和DNA去甲基化剂的组合增强非小细胞肺癌低剂量电离辐射的治疗效果。
6. Biological Effect of a Hybrid Anticancer Agent Based on Kinase and Histone Deacetylase Inhibitors on Triple-Negative (MDA-MB231) Breast Cancer Cells [O] . Mariangela Librizzi, John Spencer, Claudio Luparello 2016

机译：基于激酶和组蛋白去乙酰化酶抑制剂的混合抗癌剂对三阴性（MDA-MB231）乳腺癌细胞的生物学效应
7. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells [O] . Samiha Mateen, Komal Raina, Anil K. Jain, 2012

机译：组蛋白脱乙酰酶抑制剂与非小细胞肺癌细胞中硅蛋白组合的抗癌效果和P21-Cyclin B1 Nexus

The Anticancer Effect of Histone Deacetylase Inhibitors and Combination with the Cytotoxic Agents in Lung Cancer Cells: Biological Analyses for Future Clinical Application

著录项

引文网络

相似文献

相关主题

期刊订阅